Evidence map›Paper›PMID 31597569›Full record

ArticleMicrobial cell factories2019

Biosynthesis of rhamnolipid by a Marinobacter species expands the paradigm of biosurfactant synthesis to a new genus of the marine microflora.

Lakshmi Tripathi, Matthew S Twigg, Aikaterini Zompra, Karina Salek, Victor U Irorere, Tony Gutierrez, Georgios A Spyroulias, Roger Marchant, Ibrahim M Banat

Abstract read
In one paragraph

Article in Microbial cell factories, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Molecular Mechanisms Underlying the Pathogenicity ofMedicina (Kaunas, Lithuania) · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Draft Genome Sequence ofMicrobiology resource announcements · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lakshmi TripathiSchool of Biomedical Sciences, Ulster University, Coleraine, BT521SA, Northern Ireland, UK. l.tripathi@ulster.ac.uk.ORCID http://orcid.org/0000-0002-8926-5923
Matthew S TwiggSchool of Biomedical Sciences, Ulster University, Coleraine, BT521SA, Northern Ireland, UK.
Aikaterini ZompraDepartment of Pharmacy, University of Patras, 26504, Patras, Greece.
Karina SalekInstitute of Mechanical, Process & Energy Engineering, School of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh, EH14 4AS, UK.
Victor U IrorereSchool of Biomedical Sciences, Ulster University, Coleraine, BT521SA, Northern Ireland, UK.
Tony GutierrezInstitute of Mechanical, Process & Energy Engineering, School of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh, EH14 4AS, UK.
Georgios A SpyrouliasDepartment of Pharmacy, University of Patras, 26504, Patras, Greece.
Roger MarchantSchool of Biomedical Sciences, Ulster University, Coleraine, BT521SA, Northern Ireland, UK.
Ibrahim M BanatSchool of Biomedical Sciences, Ulster University, Coleraine, BT521SA, Northern Ireland, UK.

Funding

Horizon 2020 Framework Programme 635340 MARISURF
6 · The paper itself

Abstract

backgroundIn comparison to synthetically derived surfactants, biosurfactants produced from microbial culture are generally regarded by industry as being more sustainable and possess lower toxicity. One major class of biosurfactants are rhamnolipids primarily produced by Pseudomonas aeruginosa. Due to its pathogenicity rhamnolipid synthesis by this species is viewed as being commercially nonviable, as such there is a significant focus to identify alternative producers of rhamnolipids.

resultsTo achieve this, we phenotypically screened marine bacteria for biosurfactant production resulting in the identification of rhamnolipid biosynthesis in a species belonging to the Marinobacter genus. Preliminary screening showed the strain to reduce surface tension of cell-free supernatant to 31.0 mN m

conclusionsThis study expands the paradigm of rhamnolipid biosynthesis to a new genus of bacterium from the marine environment. Rhamnolipids produced from Marinobacter have prospects for industrial application due to their potential to be synthesised from cheap, renewable feed stocks and significantly reduced pathogenicity compared to P. aeruginosa strains.

Indexed as

FermentationGlycolipidsMarinobacterSurface-Active AgentsGlycolipidsrhamnolipidSurface-Active AgentsBiosurfactantGlycolipidHPLC–MSMarine bacteriaMarinobacterRhamnolipid

Identifiers

PMID31597569
PMCPMC6785906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.